Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
Recruiting
N/A
Interventional Study
Cholangiocarcinoma
Colorectal Cancer
Multiple Myeloma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 240 (estimated)
- Sponsor
- Washington University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Eligibility Criteria:
* Enrolled in the WU-PE-CGS study (IRB#202106129); that eligibility entails:
* Diagnosis of cholangiocarcinoma
* Diagnosis of multiple myeloma, must be African American
* Diagnosis of colorectal cancer, must be African American and age 65 or older at time of diagnosis
*…
Contacts